Is there a nonnegligible effect of maximum standardized uptake value in the staging and management of prostate cancer with 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography imaging? A single-center experience
| Autor: | SinanLevent Kirecci, Ozgul Ekmekcioglu, AbdullahHizir Yavuzsan, Pelin Arıcan |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Glutamate Carboxypeptidase II Male Standardized uptake value Gallium Radioisotopes Single Center Management of prostate cancer Positron Emission Tomography Computed Tomography medicine Glutamate carboxypeptidase II Humans Radiology Nuclear Medicine and imaging Gallium Isotopes Aged Retrospective Studies Aged 80 and over medicine.diagnostic_test business.industry Prostatic Neoplasms General Medicine Middle Aged Prognosis Oncology Positron emission tomography Antigens Surface Tomography business Nuclear medicine Follow-Up Studies |
| Zdroj: | Journal of cancer research and therapeutics. 17(6) |
| ISSN: | 1998-4138 |
| Popis: | Prostate-specific membrane antigen (PSMA) positron emission tomography/computerized tomography (PET/CT) has been shown to have significant success in detecting local and distant metastases that cannot not be detected by conventional imaging. Initial staging in intermediate- and high-risk patients with prostate cancer is important for management. In addition, PSMA uptake has been shown to have a relation with grade of disease, and thus could be considered a separate noninvasive prognostic factor. In this study, we aimed to investigate the effect of PSMA PET/CT in the staging and management of prostate cancer patients as well as the relation to maximum standardized uptake value (SUVmax).The patients referred to our department for staging prostate cancer were evaluated retrospectively (n = 65). Patients were grouped as positive for lymph node or distant metastatic disease. Primary tumor SUVmax data were compared with the prognostic factors of the disease. In addition, decisions about treatment protocol before and after PSMA PET/CT imaging were noted.All the patients except one were accepted as positive for primary tumor. Of the patients, 46.2% were positive for lymph node and 24.6% for distant metastases. After evaluation by PSMA PET/CT, the clinical choice of treatment changed for 43.1% of our patients. Primary tumor SUVmax and tumor-to-background SUVmax ratios were found to have a significant relation with D'Amico risk classification. We found a positive correlation between SUVmax and prostate-specific antigen, Gleason scores, and age.PSMA PET/CT images have a nonnegligible effect on staging, clinical decisions, and change in treatment protocol. SUVmax data have a positive correlation with risk classification and could be identified as a potential independent and non-invasive prognostic factor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|